| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Dec 12, 2025 | Buy(P) | 16.7M | $21.00 | $350.0M | 113.3M |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-045409) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Immunovant, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.